» Articles » PMID: 3556115

Expression of HLA Antigens in Paraffin Sections of Uveal Melanomas

Overview
Journal Doc Ophthalmol
Specialty Ophthalmology
Date 1986 Dec 30
PMID 3556115
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Expression of histocompatibility (HLA) antigens on tumor cells may influence the recognition of these tumor cells by the immune system. Immunological recognition may influence tumor growth and patient survival. Although HLA class I and II antigens are known to be present on several tissues in the eye, their presence on ocular tumors had not yet been demonstrated. We studied the expression of these antigens on paraffin preparations of uveal melanomas. Most tumors carried class I and beta 2m antigens on most of their cells while class II antigens were less often expressed. No association with tumor cell type or tumor size was observed. Further studies will be necessary to determine the relevance of different levels of antigen expression with regard to patient survival.

Citing Articles

Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma.

Gelmi M, Verdijk R, Houtzagers L, van der Velden P, Kroes W, Luyten G Int J Mol Sci. 2023; 24(10).

PMID: 37240204 PMC: 10218684. DOI: 10.3390/ijms24108861.


HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.

Souri Z, Wierenga A, Mulder A, Jochemsen A, Jager M Cancers (Basel). 2019; 11(8).

PMID: 31394860 PMC: 6721545. DOI: 10.3390/cancers11081132.


Uveal melanoma: estimating prognosis.

Kaliki S, Shields C, Shields J Indian J Ophthalmol. 2015; 63(2):93-102.

PMID: 25827538 PMC: 4399142. DOI: 10.4103/0301-4738.154367.


HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.

Blom D, Schurmans L, de Waard-Siebinga I, de Wolff-Rouendaal D, Keunen J, Jager M Br J Ophthalmol. 1998; 81(11):989-93.

PMID: 9505825 PMC: 1722057. DOI: 10.1136/bjo.81.11.989.

References
1.
Brocker E, Suter L, Bruggen J, Ruiter D, Macher E, Sorg C . Phenotypic dynamics of tumor progression in human malignant melanoma. Int J Cancer. 1985; 36(1):29-35. DOI: 10.1002/ijc.2910360106. View

2.
Cochran A, Foulds W, Damato B, Trope G, Morrison L, Lee W . Assessment of immunological techniques in the diagnosis and prognosis of ocular malignant melanoma. Br J Ophthalmol. 1985; 69(3):171-6. PMC: 1040556. DOI: 10.1136/bjo.69.3.171. View

3.
Forsum U, Claesson K, Hjelm E, Karlsson-Parra A, Klareskog L, Scheynius A . Class II transplantation antigens: distribution in tissues and involvement in disease. Scand J Immunol. 1985; 21(5):389-96. DOI: 10.1111/j.1365-3083.1985.tb01823.x. View

4.
Bach F, van Rood J . The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med. 1976; 295(15):806-13. DOI: 10.1056/NEJM197610072951504. View

5.
Bakker M, Grumet F, FELTKAMP T, Kijlstra A . HLA-antigens in the human uvea. Doc Ophthalmol. 1986; 61(3-4):271-9. DOI: 10.1007/BF00142353. View